NEOG(Neogen Corporation) · 财务报表

NEOG(Neogen Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-05-31FY 截至 2023-05-31FY 截至 2024-05-31FY 截至 2025-05-31FY 截至 2026-05-31
营业收入$527.16M$822.45M$924.20M$894.70M$870.40M
毛利润$243.01M$405.95M$463.90M$421.40M$408.50M
营业利润$58.62M$37.52M$58.60M−$1.06B−$21.60M
净利润$48.31M−$22.87M−$9.40M−$1.09B−$7.90M
经营现金流$68.04M$41.03M$35.30M$58.20M$83.20M
自由现金流$43.61M−$24.73M−$76.10M−$46.40M$31.90M
摊薄每股收益$0.45$-0.12$-0.04$-5.03$-0.04

Neogen Corporation NEOG